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ABSTRACT We studied the effects of self-administered (SA) vs. experimenter-ad-
ministered (EA) morphine on dendritic spines in the hippocampal formation (CA1 and
dentate), nucleus accumbens shell (NAcc-s), sensory cortex (Par1 and Oc1), medial
frontal cortex (Cg3), and orbital frontal cortex (AID) of rats. Animals in the SA group
self-administered morphine in 2-h sessions (0.5 mg/kg/infusion, i.v.) for an average of 22
sessions and animals in the EA group were given daily i.v. injections of doses that
approximated the total session dose for matched rats in Group SA (average cumulative
dose/session of 7.7 mg/kg). Control rats were given daily i.v. infusions of saline. One
month after the last treatment the brains were processed for Golgi-Cox staining. In most
brain regions (Cg3, Oc1, NAcc-s) morphine decreased the density of dendritic spines,
regardless of mode of administration (although to a significantly greater extent in Group
SA). However, only SA morphine decreased spine density in the hippocampal formation
and only EA morphine decreased spine density in Par1. Interestingly, in the orbital
frontal cortex morphine significantly increased spine density in both Groups SA and EA,
although to a much greater extent in Group SA. We conclude: 1) Morphine has persistent
(at least 1 month) effects on the density of dendritic spines in many brain regions, and
on many different types of cells (medium spiny neurons, pyramidal cells, and granule
cells); 2) The effect of morphine on spine density (and presumably synaptic organization)
varies as a function of both brain region and mode of drug administration; and 3) The
ability of morphine to remodel synaptic inputs in a regionally specific manner may
account for the many different long-term sequelae associated with opioid use. Synapse
46:271–279, 2002. © 2002 Wiley-Liss, Inc.
INTRODUCTION
Manipulation of opioid systems in the brain is known to
produce morphological changes in the structure of neu-
rons and their dendritic processes. For example, if admin-
istered early in development opioid drugs, such as mor-
phine, decrease the complexity of dendrites on cells in the
neocortex and hippocampus (Ricalde and Hammer,
1990). The blockade of endogenous opioid receptors has
the opposite effect (Hauser et al., 1987, 1989), which may
reflect alterations in the influence of endogenous opioids
on neuronal development. But opioids also affect neuro-
nal morphology when administered in adulthood. For
example, the chronic administration of morphine via a
subcutaneous implant decreases the size of dopamine cell
bodies in the ventral tegmental area (Sklair-Tavron et al.,
1996). In addition, repeated, intermittent i.p. injections of
morphine decrease dendritic aborization and the density
of dendritic spines on neurons in the nucleus accumbens
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shell (NAcc-s), medial prefrontal cortex, and parietal cor-
tex of rats (Robinson and Kolb, 1999b). These effects of
morphine on dendritic structure may reflect a drug-in-
duced reorganization of brain circuits that mediate the
actions of morphine and thus may be related to some of
the persistent sequelae associated with morphine use.
In all previous preclinical studies on the effects of
opioid administration on neuronal structure morphine
was administered by an experimenter. In considering
the extent to which these studies may inform about the
effects of drug use and abuse in humans, however, it is
important to recognize that the neurobiological effects
of drugs administered by an experimenter are not al-
ways the same as those observed when drugs are self-
administered (Dworkin, 1995; Mark et al., 1999; Smith
and Dworkin, 1990; Stefanski et al., 1999; Wilson et al.,
1994). The purpose of the present experiment, there-
fore, was to determine if self-administered morphine in
rats has similar effects on the density of dendritic
spines as experimenter-administered morphine. We
compared the effects of self-administered morphine
and experimenter-administered morphine on spine
density in four brain regions shown previously to be
sensitive to morphine: the NAcc-s, prefrontal cortex
(medial frontal cortex and orbital frontal cortex), sen-
sory cortex (primary somatosensory and primary vi-
sual cortex), and hippocampal formation (CA1 and den-
tate gyrus). To be sure any changes were relatively
persistent, animals were studied 1 month after their
last drug treatment. We report that morphine has
widespread effects on the density of dendritic spines,
but its effects vary greatly both as a function of brain




Male Sprague-Dawley rats weighing between 200–
225 g at the beginning of the experiment were housed
singly in clear plastic cages in a temperature and hu-
midity controlled room, with a 14:10-h light:dark cycle
(lights on at 7:00 AM). After a week all rats were mildly
food-deprived to about 90% of normal body weight by
restricting the number of food pellets available in the
home cages. Controlled feeding was maintained
throughout the self-administration phase of the exper-
iment. Animals were then randomly assigned to one of
three groups: a group to be trained to self-administer
morphine (SA), one to receive experimenter-adminis-
tered morphine (EA), and one to receive EA saline
(control, Ctl).
Procedures
Animals in the SA group were first trained to bar
press (FR1) for 45 mg Noyes food pellets in an operant
chamber (Med Associates). Each chamber had two le-
vers and responses on both levers were recorded but
only one had programmed consequences. Each press on
the active lever resulted in presentation of a food pellet
and a 1.5-sec period during which a cue light over the
active lever went off and white noise and the house
light were turned on. Each animal was trained daily in
one 60-min test session until they acquired stable re-
sponding, which took an average of 5 days. During this
time animals in the EA and Ctl groups were removed
from their home cage each day and placed in a test
chamber for 60 min, after which time they were placed
back into their home cage.
After animals in the SA group acquired stable re-
sponding for food, all animals in all groups underwent
surgery to implant a chronic indwelling catheter in the
right external jugular vein. The surgical procedures
were as described previously (Crombag et al., 1996;
Weeks, 1972). Briefly, rats were anesthetized using
sodium pentobarbital and the right jugular vein was
isolated. A silicone catheter was attached via PE tub-
ing to a backport anchored between the animals’ shoul-
der blades, similar in design to that used by Caine et al.
(1993). The other end of the catheter was placed into
the vein and tied with silk thread before the incisions
were sutured. For the duration of the experiment the
catheters were flushed daily with 100 l of heparinized
saline (30 USP/ml heparin in 0.9% buffered saline).
One day after catheter surgery the catheters were
tested for patency by injecting 200 l of thiopental
sodium (20 mg/ml). If the animal lost its righting reflex
within 5 sec of infusion the catheter was considered
patent. Animals were then allowed to recover from
surgery for at least 4 days before behavioral testing.
Four days after surgery animals in the SA group
were given a couple of additional days of food training
before they were transferred to the drug self-adminis-
tration protocol. The latter consisted of daily 2-h ses-
sions, Monday through Friday, using an FR1 schedule.
During each session the animals were placed into the
operant chambers and connected by their backport to
tubing attached to a motorized syringe. Each press on
the active lever resulted in an i.v. infusion 0.5 mg/kg of
morphine sulfate (weight of the salt) in 50 l of phos-
phate-buffered saline (PBS) over 2.8 sec. During the
subsequent 20-sec time out period, which began imme-
diately upon initiation of a morphine infusion, the
house light and white noise were turned on, the cue
light over the lever was turned off, and additional lever
presses had no programmed consequences during this
time. Once animals acquired morphine self-adminis-
tration behavior, which took 1–3 days, the schedule
was increased to FR2 for the remainder of the experi-
ment. Testing continued for a minimum of 13 sessions
and a maximum of 30 sessions (see below).
One day after animals in the SA group started self-
administration training each animal in the EA group
was paired with a specific animal in the SA group.
During the self-administration sessions animals in the
EA and Ctl groups were removed from their home cage
and transported to a test chamber, where they received
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an i.v. infusion of either morphine (EA) or PBS (Ctl).
The dose for each animal in the EA group consisted of
the total dose self-administered by its matched SA
animal the previous day. On a given day, if this dose
was below 2–3 mg/kg it was given as a single bolus
infusion in 50 l of PBS. When the dose to be admin-
istered was larger, however, there was a danger of a
lethal overdose. In these cases 10 mg of morphine per
200 l of PBS was given in multiple bolus infusions
over a greater period of time (12–18 min using a mo-
torized pump) and the number of injections depended
on the total dose required. For example, if a total dose
of 9 mg/kg was required it was given in three separate
injections of 3 mg/kg each spaced over a total of 10–12
min. This procedure ensured that the total dose re-
ceived each day by animals in the EA group was the
same as animals in the SA group, although, of course,
this did not match the pattern of administration or
pharmacokinetic profile. This procedure was used be-
cause we were primarily interested in comparing ani-
mals given injections by an experimenter, in a similar
fashion as might occur in a typical sensitization exper-
iment, with animals that self-administered morphine,
but at the same time controlling for at least the total
dose received each day. Animals in the Ctl group were
paired with one of the animals in the EA group and
received an equal volume of PBS. After their injections
animals in the EA and Ctl groups were left in the test
cages for 2 h before they were returned to their home
cage.
Four rats in the SA group maintained patent cathe-
ters for at least 2 weeks of self-administration testing
and data analysis is based on these four animals in the
SA group, on four matched animals in the EA group
and four animals in the Ctl group. Of the four rats in
the SA group one was tested for 13 sessions, one for 17
sessions, one for 28 sessions, and one for 30 sessions.
The mean (SEM) intake of morphine/session for these
animals was 7.66  1.2 mg/kg (range, 5.15–10.8 mg/
kg/session). The mean dose/session for rats in the EA
group was 7.73  0.59 mg/kg. All rats received close to
their average dose/session with 2–3 days of training. In
most cases where testing was discontinued it was be-
cause the catheter ceased to be patent.
Anatomical procedures
Following the final test session, all animals were left
undisturbed for 1 month. After this the animals were
given a lethal injection of sodium pentobarbital and
then were perfused through the heart with 0.9% saline.
The brains were removed and placed in light-tight vials
containing Golgi-Cox solution (Gibb and Kolb, 1998).
After 14 days the brains were transferred to a 30%
sucrose solution for at least 3 days, before coronal sec-
tions (200 m) were obtained using a vibrating mi-
crotome. The sections were placed on 2% gelatin-coated
slides and stained using procedures described in detail
by Gibb and Kolb (1998).
Cells in four brain regions were selected for analysis.
These regions were chosen because in previous studies
all have been shown to undergo plastic changes either
in response to repeated exposure to drugs of abuse or to
other kinds of experiences. The regions/cells that were
examined included (terminology according to Zilles,
1985; Zilles et al., 1990): 1) hippocampal formation
(pyramidal cells in the CA1 and dentate granule cells).
2) Sensory cortex, including pyramidal cells in layer III
of primary somatosensory cortex (Par1) and pyramidal
cells in layer III of primary visual cortex (Oc1). 3)
Prefrontal cortex, including pyramidal cells in layer V
of the medial frontal cortex (Cg3) and pyramidal cells
in layer III of the orbital region (specifically, area AID,
agranular insular cortex). These are the two portions of
rat frontal cortex that receive inputs from the me-
diodorsal nucleus of the thalamus (which defines them
as prefrontal cortex), and they are also the two main
dopamine terminal regions in rat frontal cortex (Kolb,
1990; Lindvall et al., 1978). 4) Nucleus accumbens
(NAcc-s, medium spiny neurons in the shell).
For each region/cell type we calculated the density of
dendritic spines on terminal dendrites and for pyrami-
dal cells separate measurements were obtained for api-
cal and basilar dendrites. The relevant brain region
was first identified at low power (100) and then spe-
cific cells from each hemisphere identified at 250. In
order to be included in the analysis the dendritic tree of
a cell had to be intact (i.e., largely in the 200 m section
and not obscured by blood vessels or astrocytes). Spine
density was calculated by using camera lucida to trace
a length of dendrite (at least 20 m long) at 1,000.
The exact length of the dendritic segment was calcu-
lated and the number of spines along the entire length
counted. For apical dendrites of Par1, Oc1, AID, Cg3,
and CA1 pyramidal cells spines were counted on one
third-order terminal tip (i.e., a terminal branch). For
basilar dendrites of Par1, Oc1, AID, and Cg3 pyramidal
cells spines were counted on one fourth-order terminal
tip (and from a third-order terminal tip for CA1 cells).
For medium spiny neurons, spines were counted on a
third-order terminal tip. For dentate granule cells,
spines were counted on second- or third-order terminal
dendrites. One dendrite was examined per neuron. No
attempt was made to correct for the fact that spines
directly below and above the plane of view could not be
seen, so this measure necessarily underestimates total
spine number. The values for at least five cells in each
hemisphere of each rat were averaged and hemisphere
was used as the unit of analysis. All quantification was
performed by the same person (G.G.), who was blind to
experimental condition.
RESULTS
In the NAcc-s, Oc1 and Cg3 morphine significantly
decreased the density of dendritic spines regardless of
mode of drug administration, although in some regions
(NAcc-s, Oc1-apical, Cg3-basilar) the effect of self-ad-
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ministered morphine was significantly greater than
the effect of experimenter-administered morphine
(Figs. 1, 2, 3; see figure legends for statistics). In Par1,
however, morphine decreased spine density only in
animals that were administered morphine by the ex-
perimenter; there was no effect of self-administered
morphine on spine density on either the apical or basi-
lar dendrites of pyramidal cells in Par1 (Fig. 3). In
contrast, the opposite pattern was seen in the hip-
pocampal formation. Morphine significantly decreased
spine density on CA1 pyramidal cells and dentate gran-
ule cells only in animals that self-administered mor-
phine; the effect of experimenter-administered mor-
phine was nonsignificant (Fig. 4).
The effect of morphine on pyramidal cells in AID
differed from that seen in any of the other brain regions
studied. In AID morphine significantly increased spine
density on both apical and basilar dendrites of pyrami-
dal cells, whether morphine was self-administered or
administered by the experimenter (although the effect
of self-administered morphine was much larger than
the effect of experimenter-administered morphine;
Fig. 2).
Fig. 1. The density of dendritic spines (spines/10 m) on medium
spiny neurons in the shell of the nucleus accumbens of rats given
intravenous saline (Ctl), experimenter-administered morphine (EA),
or self-administered morphine (SA). The data were analyzed using
analysis of variance and Scheffé tests were used for pairwise compar-
isons. There were significant group differences (F[2,21]  136, P 
0.001). *Significantly different from the Ctl group; †Significantly
different from the EA group (Scheffé tests).
Fig. 2. The density of dendritic spines (spines/10 m) in two pre-
frontal cortical regions, layer V pyramidal cells in Cg3 and layer III
pyramidal cells in AID (terminology of Zilles, 1985). These are the two
major frontal areas to receive input from the mediodorsal thalamus
and dopamine projections from the midbrain. Rats were given intra-
venous saline (Ctl), experimenter-administered morphine (EA), or
self-administered morphine (SA). The “a” suffix refers to apical den-
drites and the “b” suffix to basilar dendrites. There were significant
group differences: Cg3-a, F  85.8, P  0.001; Cg3-b, F  116, P 
0.001; AID-a, F  265, P  0.001; AID-b, F  135, P  0.001.
*Significantly different from the Ctl group; †Significantly different
from the EA group (Scheffé tests).
Fig. 3. The density of dendritic spines (spines/10 m) on layer III
pyramidal cells in primary somatosensory cortex (Par1) and primary
visual cortex (Oc1). The “a” suffix refers to apical dendrites and the “b”
suffix to basilar dendrites. There were significant group differences:
Par1-a, F  173, P  0.001; Par1-b, F  63.7, P  0.001; Oc1-a,
F  5.28, P  0.02; Oc1-b, F  39.4, P  0.001. *Significantly
different from the Ctl group; †Significantly different from the EA
group (Scheffé tests).
Fig. 4. The density of dendritic spines (spines/10 m) on CA1
pyramidal cells and dentate granule cells in the hippocampal forma-
tion. The “a” suffix refers to apical dendrites and the “b” suffix to
basilar dendrites. There were significant group differences: CA1-a,
F  90.0, P  0.001; CA1-b, F  187, P  0.001; dentate, F  5.19,
P  0.02. *Significantly different from the Ctl group; †Significantly
different from the EA group (Scheffé tests).
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In addition to these effects of morphine on the den-
sity of dendritic spines, we also observed some quali-
tative effects. In the NAcc-s and Cg3, where morphine
decreased spine density, many spines appeared to be
appreciably elongated, that is, have longer stems than
in control animals. This effect is apparent in Figures
5–7, although it was not quantified. In contrast, in AID,
where morphine increased spine density, many spines
appeared to be relatively stubby, to have shorter stems
than normal (see Fig. 7). We did not observe any obvi-
ous changes in the shape of spines in the hippocampal
formation, Par1 or Oc1 (see Fig. 8).
DISCUSSION
We reported previously that repeated, intermittent
i.p. injections of morphine produce a persistent (25
days after the last morphine treatment) decrease in
dendritic branching and spine density on medium
spiny neurons in the NAcc-s and pyramidal cells in
Par1 and Cg3 (Robinson and Kolb, 1999b). Consistent
with this, we report here that repeated experimenter-
administered intravenous injections of morphine also
decreased spine density in the NAcc-s, Par1, and Cg3
(as well as on the basilar dendrites of Oc1 pyramidal
cells). As in our earlier study, this effect was evident
long (1 month) after the last exposure to morphine.
This apparent widespread reduction in dendritic com-
plexity produced by morphine is consistent with re-
ports that, when given early in development, morphine
decreases dendritic growth in the cerebral cortex and
hippocampus (Ricalde and Hammer, 1990). This latter
effect may be because morphine interferes with the
action of endogenous opioids on neuronal development,
because the blockade of opioid receptors in developing
animals has the opposite effect as morphine (Hauser et
al., 1987, 1989). Taken together, these data suggest
that endogenous opioid systems play an important role
in maintaining and regulating the structure of den-
drites and dendritic spines, both in development and in
adulthood. They further suggest that some of the long-
term effects of opioid drugs may be due to their ability
to remodel dendrites, which presumably reflects a
drug-induced reorganization of synaptic inputs onto
these dendrites.
It is possible that the morphine-induced changes in
dendritic spines described here are related to reports
that repeated exposure to morphine in adulthood can
compromise neuronal integrity in widespread regions
of the brain. For example, repeated treatment with
morphine alters neurofilament and other cytoskeletal
proteins in the cerebral cortex and ventral tegmental
area (VTA), both in animals (Beitner-Johnson et al.,
1992a; Boronat et al., 1998; Jaquet et al., 2001) and
human opioid addicts (Ferrer-Alcon et al., 2000; Gar-
cia-Sevilla et al., 1997), decreases axonal transport in
the VTA-NAcc system (Beitner-Johnson and Nestler,
1993) and decreases the size of dopamine cell bodies in
the VTA (Sklair-Tavron et al., 1996). Chronic morphine
also increases the expression of the pro-apoptotic Fas
receptor and decreases the expression of the anti-apop-
totic Bcl-2 oncoprotein in the cerebral cortex of rats
(Boronat et al., 2001), which may be related to a mor-
phine-induced inhibition of neurogenesis in the dentate
granule cell layer (Eisch et al., 2000) and/or the de-
crease in frontal lobe volume seen in opioid addicts
(Pezawas et al., 1998). The overall picture emerging
Fig. 5. Representative camera lucida drawings (2,000) of den-
drites on medium spiny neurons in the nucleus accumbens shell
(NAcc-s) of rats given intravenous saline (Ctl), experimenter-admin-
istered morphine (EA), or self-administered morphine (SA). The num-
bers at the top of each dendritic segment indicate the calculated
numbers of spines/10 m for the specific dendrite illustrated. The
scale bar indicates a distance of 10 m. Note the difference in the
shape of spines between the Ctl and the EA and SA groups. Many
spines in morphine treated animals (especially the SA group) appear
elongated relative to Ctl, despite the reduction in spine density.
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from these studies is that repeated exposure to mor-
phine damages neurons (Nestler, 1996).
On the other hand, the data presented here suggest
that morphine does not have generalized neurodegen-
erative effects (at least as indicated by changes in spine
density), because its effects on dendritic structure were
not uniform across different brain regions, nor mode of
drug administration. In some brain regions (NAcc-s,
Cg3, Oc1) morphine did decrease spine density, regard-
less of mode of drug administration, and the effect of
self-administered morphine was generally greater than
the effect of experimenter-administered morphine. But
in the hippocampal formation (CA1 and dentate gyrus)
morphine decreased spine density only when it was
self-administered, and in Par1 morphine decreased
spine density only when it was experimenter-adminis-
tered. The different effects of morphine in different
subregions of the prefrontal cortex were especially
striking. As noted above, in the medial frontal cortex
(Cg3) morphine decreased spine density, but in a
closely related orbital frontal region (AID) morphine
produced a large increase in spine density, which was
especially dramatic in animals with self-administra-
tion experience.
Fig. 6. Photomicrographs of representative dendrites from NAcc-s medium spiny neurons illustrating
spines in a control animal (Ctl) and an animal that self-administered morphine (SA).
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This regional specificity is not explained by just con-
sidering cell type. Although there was a decrease in
spines on all three types of cells studied (medium spiny
neurons, pyramidal cells, and granule cells), there was
an increase in spine density on pyramidal cells in AID.
The effect of morphine also did not vary as a function of
total dose, because the EA and SA groups were exposed
to the same total daily dose. There were, however,
marked group differences in morphine pharmacokinet-
ics. The EA group received bolus injections over a rel-
atively short period of time (minutes), whereas the SA
group took many small infusions over a 2-h session,
which would maintain relatively high blood levels of
the drug for a much more sustained period of time. It is
possible that sustained blood levels might be more
toxic, as is the case with psychostimulant drugs (Rob-
inson and Becker, 1986). But self-administered mor-
phine did not consistently produce a larger effect than
experimenter-administered drug. In Par1 only experi-
menter-administered morphine had any effect, and in
some regions there was no difference in the effect of
experimenter- and self-administered morphine (e.g.,
Cg3-a, Oc1-b). The fact that different modes of drug
administration has such different effects in some brain
regions is consistent with previous reports that self-
administered drugs and experimenter-administered
drugs sometimes have different neurobiological effects
(Dworkin, 1995; Mark et al., 1999; Smith and Dworkin,
1990; Stefanski et al., 1999; Wilson et al., 1994).
The regional specificity of the effects described here
has important implications in thinking about the
mechanisms by which morphine, and associated
changes in opioid neurotransmission, shape the struc-
ture of dendrites. The results suggest that repeated
treatment with morphine does not alter spine density
due to the action of morphine on some ubiquitous,
brain-wide growth factor. To the extent that the effect
Fig. 7. Representative camera lucida drawings (2,000) of den-
drites from prefrontal cortical pyramidal cells in Cg3-b (where there
was a decrease in spine density in animals that self-administered
morphine) and AID-a (where there was an increase in spine density in
animals that self-administered morphine). Note that in Cg3 many
spines appear to have elongated stems in group SA, relative to Ctl,
whereas in AID many spines in group SA appear to be more stubby,
with shortened stems, relative to Ctl. Scale bar  10 m.
Fig. 8. Representative camera lucida drawings (2,000) of den-
drites from pyramidal cells in Par1-a (where there was a decrease in
spine density only in the EA group), and CA1-b pyramidal cells in the
hippocampal formation (where there was a decrease in spine density
only in the SA group). Note that there are no obvious group differ-
ences in the shape of the spines. Scale bar  10 m.
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of morphine on spine density is mediated by its effect
on growth factors (Messer et al., 2000), neurofilament
proteins (Beitner-Johnson et al., 1992b; Boronat et al.,
1998), or other molecules that regulate neuronal and
synaptic structure (Nestler, 1996), the actions of such
agents must also vary regionally, and as a function of
mode of drug administration. Indeed, the specificity of
the effects described here may provide an excellent
avenue to delineate mechanisms that are causally re-
lated to the action of morphine on dendritic structure.
If one hypothesizes, for example, that a given molecule
is critical for morphine to alter synaptic organization
(at least as indicated by changes in spine density), then
in the Par1 only experimenter-administered morphine
should have an effect on the molecule under study, in
the hippocampal formation only self-administered mor-
phine should have an effect, and in Cg3 and AID one
might predict opposite effects. Of course, it is also pos-
sible that the effects of morphine on synaptic organi-
zation in different types of cells in different brain re-
gions are mediated by entirely different mechanisms.
Whatever the case, it is clear that in studies exploring
the molecular mechanisms responsible for shaping the
structure of dendrites, and associated patterns of syn-
aptic connectivity, it will be important to study very
specific brain regions and cell types, and perhaps even
specific portions of a dendritic tree, and to not lump
samples into broad anatomical categories, such as “the
cerebral cortex.”
The alterations in spine density reported here pre-
sumably reflect a reorganization of synapses on these
cells (Harris and Kater, 1994; Shephard, 1996), al-
though this cannot be established with certainty with-
out additional ultrastructural studies. Nevertheless,
there is considerable evidence from studies of other
forms of experience-dependent plasticity that the kinds
of changes seen here in Golgi-stained material are as-
sociated with alterations in patterns of synaptic con-
nectivity (Greenough et al., 1990; Ingham et al., 1998;
Kolb et al., 1998; Purves, 1994; Woolley, 1999). Given
that the changes in dendritic spines do reflect a reor-
ganization of synaptic inputs onto these cells, they
must have functional consequences for the operation of
the neural systems in which these cells are embedded.
We can only speculate what the functional conse-
quences might be. Repeated exposure to morphine has
many persistent effects on behavior. For example, re-
peated treatment with morphine produces a persistent
increase (sensitization) in the behavioral activating
and the incentive properties of the drug (De Vries and
Shippenberg, 2002; Robinson and Berridge, 2000),
which could be related to the reorganization of NAcc
and prefrontal circuits. There is also accumulating ev-
idence for “distinct patterns of cognitive impairment”
in opioid addicts (Ornstein et al., 2000; Rogers et al.,
1999; Rogers and Robbins, 2001), which could be re-
lated to remodeling of the hippocampal formation and
frontal cortex. Changes in the organization of sensory
cortical areas may even contribute to deficits on some
learning tasks seen in addicts, such as tactual perfor-
mance tasks (Hill and Mikhael, 1979), due to changes
in sensory functions.
In conclusion, and as put by Ornstein et al. (2000),
the challenge for the future will be in “matching such
patterns of anatomical connectivity to similar brain
changes in human drug users and associated, possibly
drug-specific, changes in cognitive function” (p. 124),
and, we would add, in incentive motivational function.
This challenge is further complicated by the fact that
the effects of other drugs of abuse on dendritic struc-
ture are very different than described here for mor-
phine (Brown and Kolb, 2001; Robinson and Kolb,
1997, 1999a,b; Robinson et al., 2001). The challenge,
therefore, will be in unraveling the relationship be-
tween alterations in patterns of synaptic connectivity
in a specific circuit to the operation of the circuit, and
finally to associated changes in behavioral or psycho-
logical functions. Nevertheless, the data presented
here suggest that repeated exposure to morphine ini-
tiates a widespread reorganization of brain regions
that mediate cognitive functions, including those asso-
ciated with judgment and impulsivity, as well as brain
regions associated with incentive motivational func-
tions, and together these may contribute to the devel-
opment of the compulsive patterns of drug-seeking and
drug-taking behavior that characterize addiction
(Jentsch and Taylor, 1999; Robinson and Berridge,
2000, 2003; Rogers and Robbins, 2001).
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